![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SYNRG |
Gene summary for SYNRG |
![]() |
Gene information | Species | Human | Gene symbol | SYNRG | Gene ID | 11276 |
Gene name | synergin gamma | |
Gene Alias | AP1GBP1 | |
Cytomap | 17q12 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q9UMZ2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
11276 | SYNRG | GSM4909292 | Human | Breast | IDC | 4.09e-02 | 5.21e-01 | 0.1236 |
11276 | SYNRG | GSM4909317 | Human | Breast | IDC | 1.47e-02 | 2.41e-01 | 0.1355 |
11276 | SYNRG | GSM4909319 | Human | Breast | IDC | 2.19e-02 | -9.67e-03 | 0.1563 |
11276 | SYNRG | NCCBC14 | Human | Breast | DCIS | 2.20e-15 | 6.87e-01 | 0.2021 |
11276 | SYNRG | DCIS2 | Human | Breast | DCIS | 5.65e-38 | 1.94e-01 | 0.0085 |
11276 | SYNRG | LZE4T | Human | Esophagus | ESCC | 8.93e-07 | 3.20e-01 | 0.0811 |
11276 | SYNRG | LZE7T | Human | Esophagus | ESCC | 5.05e-13 | 6.08e-01 | 0.0667 |
11276 | SYNRG | LZE8T | Human | Esophagus | ESCC | 4.99e-04 | 1.92e-01 | 0.067 |
11276 | SYNRG | LZE20T | Human | Esophagus | ESCC | 4.68e-07 | 1.99e-01 | 0.0662 |
11276 | SYNRG | LZE22T | Human | Esophagus | ESCC | 3.55e-02 | 2.28e-01 | 0.068 |
11276 | SYNRG | LZE24T | Human | Esophagus | ESCC | 2.26e-19 | 5.41e-01 | 0.0596 |
11276 | SYNRG | LZE21T | Human | Esophagus | ESCC | 8.21e-05 | 2.92e-01 | 0.0655 |
11276 | SYNRG | P1T-E | Human | Esophagus | ESCC | 1.20e-12 | 4.89e-01 | 0.0875 |
11276 | SYNRG | P2T-E | Human | Esophagus | ESCC | 4.19e-30 | 3.86e-01 | 0.1177 |
11276 | SYNRG | P4T-E | Human | Esophagus | ESCC | 1.23e-16 | 3.91e-01 | 0.1323 |
11276 | SYNRG | P5T-E | Human | Esophagus | ESCC | 2.53e-14 | 1.94e-01 | 0.1327 |
11276 | SYNRG | P8T-E | Human | Esophagus | ESCC | 2.29e-22 | 3.75e-01 | 0.0889 |
11276 | SYNRG | P9T-E | Human | Esophagus | ESCC | 2.65e-10 | 1.82e-01 | 0.1131 |
11276 | SYNRG | P10T-E | Human | Esophagus | ESCC | 1.96e-13 | 2.08e-01 | 0.116 |
11276 | SYNRG | P11T-E | Human | Esophagus | ESCC | 3.50e-14 | 4.98e-01 | 0.1426 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SYNRG | SNV | Missense_Mutation | novel | c.1505N>C | p.Leu502Pro | p.L502P | Q9UMZ2 | protein_coding | deleterious(0) | probably_damaging(0.957) | TCGA-G4-6586-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SYNRG | SNV | Missense_Mutation | novel | c.2360N>C | p.Ile787Thr | p.I787T | Q9UMZ2 | protein_coding | tolerated_low_confidence(0.9) | benign(0) | TCGA-G4-6628-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
SYNRG | SNV | Missense_Mutation | novel | c.1994N>A | p.Ser665Asn | p.S665N | Q9UMZ2 | protein_coding | deleterious(0.02) | benign(0.005) | TCGA-NH-A6GB-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | oxaliplatin | SD |
SYNRG | SNV | Missense_Mutation | novel | c.1961C>T | p.Thr654Ile | p.T654I | Q9UMZ2 | protein_coding | tolerated(0.06) | benign(0.073) | TCGA-CL-4957-01 | Colorectum | rectum adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | oxaliplatin | SD |
SYNRG | SNV | Missense_Mutation | novel | c.3513N>T | p.Leu1171Phe | p.L1171F | Q9UMZ2 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SYNRG | SNV | Missense_Mutation | novel | c.3218N>C | p.Ser1073Thr | p.S1073T | Q9UMZ2 | protein_coding | deleterious(0.03) | probably_damaging(0.99) | TCGA-G5-6235-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | oxaliplatin | PD |
SYNRG | deletion | Frame_Shift_Del | novel | c.1829delN | p.Asn610ThrfsTer3 | p.N610Tfs*3 | Q9UMZ2 | protein_coding | TCGA-AA-3950-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
SYNRG | deletion | Frame_Shift_Del | novel | c.1829delN | p.Asn610ThrfsTer3 | p.N610Tfs*3 | Q9UMZ2 | protein_coding | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
SYNRG | insertion | Frame_Shift_Ins | novel | c.3813dupA | p.Ala1272SerfsTer41 | p.A1272Sfs*41 | Q9UMZ2 | protein_coding | TCGA-F4-6856-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Ancillary | leucovorin | CR | ||
SYNRG | SNV | Missense_Mutation | novel | c.3220N>G | p.Leu1074Val | p.L1074V | Q9UMZ2 | protein_coding | deleterious(0.04) | probably_damaging(0.995) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |